NOVO VENTURES

novo-ventures-logo

Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo Group and as such the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S. Novo A/S was established in 1999 prior to the demerger of Novo Nordisk A/S, where Novozymes A/S was established as a stand-alone publicly listed company. Novo's purpose and objectives are to manage the Foundation's financial assets and to ensure the... Foundation sufficient dividends to cover its grant obligations for medical and scientific research etc. in Scandinavia. Novo A/S attains these objectives through: compliance with the rules and principles which are set out in the Articles of Association of the Novo Nordisk Foundation regarding exercise of the voting rights of A and B shares in Novo Nordisk A/S and Novozymes A/S, respectively, assurance that all companies in which the company has a material influence actively contribute to the development of the Novo Group and operate their business in accordance with the visions and values of the Novo Group, maintenance of a material influence on Novo Nordisk A/S and Novozymes A/S, and investment and financing business including placing of capital in companies and real property domestically and abroad. Novo’s overall investment strategy is thus to maintain ownership of Novo Nordisk’ and Novozymes’ shares at a level just above 25% and to invest dividends from these companies and other income in the life science area as well as in a broad portfolio of financial assets. Novo A/S has since 1999 established itself as an international venture capital partner in the life science area and has invested in over 50 companies in Denmark, Europe and North America. Through its financial investment activities Novo A/S seeks to spread the company’s total financial risk and at the same time to ensure a high return taking into consideration the chosen risk profile. In 2007 Novo A/S together with the Novo Nordisk Foundation established ‘Novo Seeds’. The new program (split into two sub-programs) is aimed at supporting early stage applied research in the life science area in Scandinavia. At the beginning of 2009 Novo A/S launched a new initiative, investing 'growth equity' into promising later stage/commercial stage life science companies. Novo A/S represents the interests of the Novo Nordisk Foundation through participation on the boards of the companies in the Novo Group. The companies in the Novo Group are members of a 'family of companies', independently managed, but sharing a set of common values as set out in the 'Charter for Companies in the Novo Group'. In the Charter these core values, commitments and management principles that companies in the Novo Group should live up to are described.

#SimilarOrganizations #People #Financial #More

NOVO VENTURES

Industry:
Asset Management Finance Social

Founded:
1999-01-01

Status:
Active

Technology used in webpage:
Viewport Meta Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Apache Mobile Non Scaleable Content Sitelinks Search Box Euro


Similar Organizations

janus-henderson-investors-logo

Janus Henderson Investors

Janus Henderson Investors is an asset manager that helps their clients achieve their financial goals.

scottish-enterprise-logo

Scottish Enterprise

Scottish Enterprise is Scotland's main economic, enterprise, innovation and investment agency.

Current Employees Featured

brigid-hughes_image

Brigid Hughes
Brigid Hughes Operations Manager @ Novo Ventures
Operations Manager

peter-bisgaard_image

Peter Bisgaard
Peter Bisgaard Partner & Investment Manager @ Novo Ventures
Partner & Investment Manager
2009-01-01

peter-moldt_image

Peter Moldt
Peter Moldt Partner @ Novo Ventures
Partner

eric-shiozaki_image

Eric Shiozaki
Eric Shiozaki Principal @ Novo Ventures
Principal

kasim-kutay_image

Kasim Kutay
Kasim Kutay CEO @ Novo Ventures
CEO

nilesh-kumar_image

Nilesh Kumar
Nilesh Kumar Partner @ Novo Ventures
Partner
2017-01-01

scott-a-beardsley_image

Scott A. Beardsley
Scott A. Beardsley Partner @ Novo Ventures
Partner
2012-01-01

nilesh-kumar_image

Nilesh Kumar
Nilesh Kumar Senior Principal @ Novo Ventures
Senior Principal
2015-04-01

tiba-aynechi_image

Tiba Aynechi
Tiba Aynechi Partner @ Novo Ventures
Partner

Investments List

Date Company Article Money raised
2022-07-11 Theraxyte Novo Ventures investment in Seed Round - Theraxyte 10 M USD
2021-09-16 Amolyt Pharma Novo Ventures investment in Series B - Amolyt Pharma 80 M USD
2021-09-08 INBRACE Novo Ventures investment in Series D - INBRACE 102 M USD
2020-12-09 Reneo Pharmaceuticals Novo Ventures investment in Series B - Reneo Pharmaceuticals 95 M USD
2020-09-17 Lava Therapeutics Novo Ventures investment in Series C - Lava Therapeutics 83 M USD
2020-08-12 F2G Novo Ventures investment in Private Equity Round - F2G 60.8 M USD
2020-06-03 NodThera Novo Ventures investment in Series B - NodThera 55 M USD
2019-09-11 Anokion Novo Ventures investment in Series B - Anokion 40 M USD
2019-07-31 Amolyt Pharma Novo Ventures investment in Series A - Amolyt Pharma 67 M EUR
2018-09-19 Galera Therapeutics Novo Ventures investment in Series C - Galera Therapeutics 70 M USD

More informations about "Novo Ventures" on Search Engine